Matthew J. Crisp

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study

Timothy M. Miller, Alan Pestronk, William David et al. · The Lancet Neurology · 2013 · 603 citations · Full text

Tau Kinetics in Neurons and the Human Central Nervous System

Chihiro Sato, Nicolas R. Barthélemy, Kwasi G. Mawuenyega et al. · Neuron · 2018 · 573 citations · Full text

Neurodynamics, Neurophysiology, Synaptic Transmission +9

Altered Dosage and Mislocalization of Histone H3 and Cse4p Lead to Chromosome Loss in <i>Saccharomyces cerevisiae</i>

Wei-Chun Au, Matthew J. Crisp, Steven Z. DeLuca et al. · Genetics · 2008 · 92 citations · Full text

Histone Modifications, Histone H3, Epigenetic Change +23

In vivo kinetic approach reveals slow SOD1 turnover in the CNS

Matthew J. Crisp, Kwasi G. Mawuenyega, Bruce W. Patterson et al. · Journal of Clinical Investigation · 2015 · 62 citations · Full text

Vivo Protein Kinetics, Neurotransmission, Social Sciences +21

Canine degenerative myelopathy: Biochemical characterization of superoxide dismutase 1 in the first naturally occurring non-human amyotrophic lateral sclerosis model

Matthew J. Crisp, Jeffrey M. Beckett, Joan R. Coates et al. · Experimental Neurology · 2013 · 47 citations · Full text

Canine Degenerative Myelopathy, Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis +11